CS logo
small CS logo
Institut Jean Godinot

Reims, France
Cancer treatment center in Reims
1 Rue du Général Koenig, 51100 Reims

About Institut Jean Godinot


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
UNICANCER
61
ARCAGY/ GINECO GROUP
14
Hoffmann-La Roche
12
Centre Leon Berard
11
Centre Jean Perrin
8
Centre Oscar Lambret
7
Intergroupe Francophone de Cancerologie Thoracique
7
Pfizer
6
Centre Francois Baclesse
5
Institut Cancerologie de l'Ouest
5
Centre Hospitalier Universitaire de Besancon
4
Total Rows: 51

Clinical Trials at Institut Jean Godinot


During the past decade, Institut Jean Godinot conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 16 clinical trials were completed, i.e. on average, 18.6% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 6 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66661212121217171414997733222211114411441100Started TrialsCompleted Trails20152016201720182019202020212022202301020
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1994-12-01
2002-01-01
Completed
180
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
1997-12-01
2015-01-01
Completed
450
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
1998-10-01
2011-01-01
Completed
160
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1999-01-04
2007-03-31
Completed
350
Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
1998-10-01
2001-03-01
Terminated
160
Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
1998-03-01
2002-04-01
Completed
40
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
1998-03-01
2000-03-01
Terminated
45
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
1998-09-01
2005-09-01
Completed
36

Rows per page:

1–100 of 197

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Institut Jean Godinot" #1 sponsor was "UNICANCER" with 61 trials, followed by "ARCAGY/ GINECO GROUP" with 14 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored, "Centre Leon Berard" with 11 trials sponsored and "Centre Jean Perrin" with 11 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 51 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Jean Godinot" #1 collaborator was "National Cancer Institute, France" with 9 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator, "UNICANCER" with 6 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator and "Pfizer" with 5 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 101 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUNICANCER: 61UNICANCER: 61ARCAGY/ GINECO GROUP: 14ARCAGY/ GINECO GROUP: 14Hoffmann-La Roche: 12Hoffmann-La Roche: 12Centre Leon Berard: 11Centre Leon Berard: 11Centre Jean Perrin: 8Centre Jean Perrin: 8Centre Oscar Lambret: 7Centre Oscar Lambret: 7IntergroupeFrancophone deCancerologieThoracique: 7IntergroupeFrancophone deCancerologieThoracique: 7Pfizer: 6Pfizer: 6Centre Francois Baclesse: 5Centre Francois Baclesse: 5Institut Cancerologie del'Ouest: 5Institut Cancerologie del'Ouest: 5

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute, France: 9National CancerInstitute, France: 9AstraZeneca: 6AstraZeneca: 6UNICANCER: 6UNICANCER: 6Merck Sharp & Dohme LLC: 5Merck Sharp & Dohme LLC: 5Pfizer: 5Pfizer: 5Roche Pharma AG: 5Roche Pharma AG: 5Breast International Group: 4Breast International Group: 4Bristol-Myers Squibb: 4Bristol-Myers Squibb: 4European Organisationfor Research andTreatment of Cancer -EORTC: 4European Organisationfor Research andTreatment of Cancer -EORTC: 4Fondation ARC: 4Fondation ARC: 4

Clinical Trials Conditions at Institut Jean Godinot


According to Clinical.Site data, the most researched conditions in "Institut Jean Godinot" are "Breast Cancer" (37 trials), "Prostate Cancer" (14 trials), "Ovarian Cancer" (10 trials), "Colorectal Cancer" (8 trials) and "Cancer" (7 trials). Many other conditions were trialed in "Institut Jean Godinot" in a lesser frequency.

Clinical Trials Intervention Types at Institut Jean Godinot


Most popular intervention types in "Institut Jean Godinot" are "Drug" (135 trials), "Radiation" (28 trials), "Other" (27 trials), "Procedure" (26 trials) and "Biological" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "fluorouracil" (11 trials), "radiation therapy" (11 trials), "Docetaxel" (9 trials) and "Trastuzumab" (9 trials). Other intervention names were less common.

Clinical Trials Genders at Institut Jean Godinot


The vast majority of trials in "Institut Jean Godinot" are 104 trials for "All" genders, 69 trials for "Female" genders and 24 trials for "Male" genders.

Clinical Trials Status at Institut Jean Godinot


Currently, there are NaN active trials in "Institut Jean Godinot". 1 are not yet recruiting, 49 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 96 completed trials in Institut Jean Godinot, 2 suspended trials, and 18 terminated clinical trials to date.
Out of the total trials that were conducted in Institut Jean Godinot, 3 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 31 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 79Phase 3: 79Phase 2: 61Phase 2: 61Not Applicable: 31Not Applicable: 31Phase 1: 3Phase 1: 3Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 96Completed: 96Recruiting: 49Recruiting: 49Active, not recruiting: 26Active, not recruiting: 26Terminated: 18Terminated: 18Unknown status: 5Unknown status: 5Suspended: 2Suspended: 2Not yet recruiting: 1Not yet recruiting: 1